Welcome to Slow Release — a fortnightly series from TranslationsInLondon and GRC Health, unpacking what it really takes for a clinical questionnaire to work the same way in every language it's translated into. Each edition, we sit down with a specialist from one side of that process — translation or clinical methodology — to pull apart a single idea.
For the launch edition, we're starting at the beginning: cognitive debriefing. Val Vignolo Love, Director of TranslationsInLondon, talks to Mark Gibson, Owner & CEO of Gibson Research Consultancy, about what it is, why a technically accurate translation isn't enough on its own, and what "cognitive burden" actually looks like from the other side of the table.
Setting the scene
ValIn plain terms, what is cognitive debriefing, and where does it sit in the linguistic validation process?
Mark"It feels like a script, a catechism. Painting by numbers." That's how the textbook answer sounds to me — linguistic validation is about making sure the clinical outcome assessments patients, clinicians and caregivers complete during a study say the same thing, conceptually, in every language the trial runs in. But I'd rather call it applied patient voice research: another chance to find out not just whether patients understood a questionnaire, but what they felt, and the metaphors they reached for to explain it. There's a difference between a translation that's accurate and one that's accurate and resonates. More simply, cognitive debriefing is a research technique for testing how a concept lands across languages — part of a family of performance-based methods that also includes readability testing, teach-back, talk-aloud and usability testing.
ValWhy isn't a technically accurate translation enough on its own?
MarkBy the time a questionnaire reaches cognitive debriefing, it's already gone through at least six translation steps and ten pairs of eyes — you can see at a glance what decisions have been taken before it ever gets here. Cognitive debriefing is the step where the questionnaire is tested in the world, with real patients, and the aim is to find proof that an item has been fully understood, partially understood, or not at all. The best way to find that out is to ask someone to explain the item back in their own words. "It means what it says" or "it's clear to me" wouldn't be acceptable — that provides no proof of understanding.
"Right ingredient, wrong release mechanism — the patient never absorbs it."
The Slow Release metaphor — cognitive debriefing as the proof of doseCognitive burden, up close
ValWhat does cognitive burden actually look like in a debriefing session — what are the tell-tale signs a patient is struggling, even if they don't say so directly?
MarkThere are two kinds. The first, and most overlooked, is created by how a question is worded — bad questions lead to cognitive burden, and in this sector, bad questions are the default. Even a simple item like "in the past 4 weeks, how much difficulty have you had sleeping?" asks someone to hold several things in mind at once: the time frame, the concept of difficulty, the scale of possible answers. Translate that poorly, or implement it clumsily on an eCOA platform, and it only compounds. The second kind is really cognitive fatigue rather than burden — what happens to a patient, and an interviewer, over a long session. It's repetitive, exhausting work. I wouldn't schedule an interview over 50–55 minutes; you see a real drop-off in answer quality once people get tired.
ValIs there a moment from a real, anonymised session that illustrates this well?
MarkTesting a 450-item smoking cessation diary for a Boston-based CRO meant four-and-a-half-hour interviews — with participants recruited specifically because they wanted to quit smoking. The interviewer was breastfeeding and had to force breaks; her husband was bringing the baby to the interview. The participants were getting irritated, tetchy, and with good reason. That's the worst case I've encountered, and it's shaped how I schedule everything since — no more than an hour per interview, no more than two interviews a day. I've seen an LSP price a debriefing round as a flat $500: one hour at $100, five participants, done. That kind of calculation shows exactly how much the actual work gets underestimated.
Mark on the session that changed how he schedules debriefing.
In short: cognitive debriefing is the interview round after translation where patients talk through a questionnaire in their own words, so the team can confirm they understood each item the way it was intended.
What regulators expect
ValWhat do regulators like the FDA1 and EMA2 actually expect to see documented from a debriefing round?
MarkTransparency is what I aim for, and it's what they want. First, a report that documents every step, the findings from cognitive debriefing, and any action taken afterward. Then we offer the supporting documentation in the spirit of transparency — the translation steps, how and where patients were recruited, anonymised demographics like age, biological sex and education level, and the verbatim data itself. It's a huge volume of data to wade through, but it's there for them.
ValHow many rounds of debriefing does it typically take before a PRO/COA instrument is considered validated?
MarkNormally just one round of five participants. We retest if there are comprehension problems, with improved wording, or if the questionnaire developer wants a change or more data on a given item. There isn't an official pass/fail criterion the way there is with readability testing in the UK or EU — but retesting is something patients need to know about from the start. The interview isn't necessarily their last input; in most cases it will be, but retesting isn't unusual. It's part of the spirit of iterative design.
The one thing sponsors should know
ValWhat's the one thing you wish sponsors understood about cognitive debriefing before they budget or schedule for it?
MarkI worry about expertise being pushed further back in the decision-making chain. More and more, decisions get made at sales or procurement level — like pricing a debriefing round as five interviews for $500 — and that shows a real lack of understanding of the moving parts involved. My advice to sponsors: ask the people quoting you the work what they've actually delivered, and how, not just what they say they can do.
ValAny teaser for what Edition 2 in the series should cover?
MarkI think a good topic would be who should actually be conducting debriefing interviews — translators, or professional interviewers. And cognitive burden itself is worth a whole edition on its own.
References
- US Food and Drug Administration. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims — Guidance for Industry. December 2009. fda.gov/media/77832/download
- European Medicines Agency, CHMP. Reflection Paper on the Regulatory Guidance for the Use of Health-Related Quality of Life (HRQL) Measures in the Evaluation of Medicinal Products. ema.europa.eu